(Q37151497)

18 August 2017

The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis (English)

1 reference

stem cell transplantation

18 August 2017

0 references

1 reference

5

Michael Boeckh

1 reference

18 August 2017

3

Wendy Leisenring

1 reference

18 August 2017

Cynthia E Fisher

1

1 reference

18 August 2017

A Michal Stevens

series ordinal

2

1 reference

18 August 2017

Steven A Pergam

series ordinal

4

1 reference

18 August 2017

Tobias M Hohl

series ordinal

6

1 reference

18 August 2017

language of work or name

English

0 references

publication date

11 June 2013

1 reference

Clinical Infectious Diseases

18 August 2017

1 reference

18 August 2017

57

1 reference

18 August 2017

7

1 reference

18 August 2017

1001-1004

1 reference

Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Factors associated with mortality in transplant patients with invasive aspergillosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3765008

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease

6 September 2017

1 reference

12 December 2020

Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution

1 reference

12 December 2020

Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis

1 reference

12 December 2020

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIT393

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

23759343

1 reference